Skip to main content
. 2023 Aug 18;7:e2300214. doi: 10.1200/PO.23.00214

TABLE 2.

Genomic Signature Scores (presented as median [Q1-Q3]) and Risk Classifications (presented as n [%]) in Patients Treated With Intensified Salvage Therapy (radiation therapy with 6 months of ADT and enzalutamide) by Progression

graphic file with name po-7-e2300214-g002.jpg